Active-Empathic Listening and Student Persistence
NCT07920471, Not applicable, Completed, Al-Zaytoonah University of Jordan
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Active-Empathic Listening and Student Persistence | ClinicalTrials.gov |
| NCT number | NCT07920471 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 995 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Al-Zaytoonah University of Jordan | ClinicalTrials.gov |
| Conditions | Academic Advising, Engagement-Based Advising, Active-Empathic Listening, Undergraduate Student Retention, Undergraduate Student Persistence, Academic Achievement | ClinicalTrials.gov |
| Interventions | Engagement-Based Academic Advising, Standard Reactive Academic Advising | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Term-to-Term Undergraduate Student Retention Rate | From baseline enrollment to the end of the 2025-2026 academic year (approximately 30 weeks). | The proportion of undergraduate nursing students who remained enrolled in the subsequent major academic term. Retention was determined using institutional enrollment records and compared between students receiving engagement-based academic advising and those receiving standard reactive academic advising. | ClinicalTrials.gov |
| Secondary | Annual Credit Completion Ratio | At the end of the academic year (Week 30; 2025-2026 academic year). | The proportion of academic credits successfully earned relative to the total credits attempted during the academic year. It will be calculated as the number of earned credits divided by the number of attempted credits. The score ranges from 0 to 1, with higher scores indicating greater academic progress. Data will be extracted from official university records. | ClinicalTrials.gov |
| Secondary | Cumulative Grade Point Average (GPA) | At the end of the academic year (Week 30; 2025-2026 academic year). | Cumulative academic grade point average measured on a 4.0-point scale using official university academic records. Higher scores indicate better overall academic achievement. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)